Probiotics reduce odds of C. difficile infection during antibiotic treatment

Providing multistrain probiotics to pediatric and adult patients treated with antibiotics reduces the likelihood of Clostridium difficile infection, with no difference in serious adverse events when compared with standard care, according to research published in Infection Control & Hospital Epidemiology.
“An individual patient’s risk of developing [C. difficile infection (CDI)] differs based on numerous host and environmental factors, most importantly antibiotic exposure, which is thought to disrupt the intestinal microbiota, allowing C. difficile to proliferate,” Bradley